Related Experiment Video
Updated: Apr 6, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
Host-virus interactions in hepatitis B virus infection
Luca G Guidotti1, Masanori Isogawa2, Francis V Chisari3
1Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Hepatitis B virus (HBV) infection outcome depends on adaptive T cell responses and neutralizing antibodies. Understanding immune tolerance mechanisms is key to developing therapies for chronic HBV and preventing liver cancer.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis B virus (HBV) causes acute and chronic hepatitis.
- HBV infection does not elicit a significant innate immune response in the liver.
- Adaptive immune responses, including T cells and antibodies, are crucial in controlling HBV infection.
Purpose of the Study:
- To explore the immunological mechanisms underlying HBV infection.
- To understand the role of adaptive T cell responses and neutralizing antibodies in HBV outcomes.
- To identify targets for immunotherapeutic strategies against chronic HBV infection.
Main Methods:
- Analysis of HBV-specific T cell kinetics, breadth, vigor, trafficking, and effector functions.
- Assessment of neutralizing antibody development.
- Investigation of immunological tolerance mechanisms in HBV infection.
Main Results:
- The outcome of HBV infection is dictated by the adaptive immune response.
- Dysregulation of T cell responses or antibody production leads to persistent infection.
- Persistent HBV infection can result in chronic liver disease and hepatocellular carcinoma.
Conclusions:
- Developing effective immunotherapies requires a deeper understanding of HBV-induced immune tolerance.
- Targeting adaptive immunity is essential for curing chronic HBV infection.
- Preventing HBV-related liver cancer necessitates improved control of viral persistence.
Related Concept Videos
Hepatitis
Viruses with RNA Genomes
Inhibitors of Viral Protein Synthesis
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytomegalovirus Disease

